Sholl, L. M., Awad, M., Roy, U. B., Beasley, M. B., Cartun, R. W., Hwang, D. M., . . . Furtado, L. V. (2024). Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies. Archives of Pathology & Laboratory Medicine, 148(7), 757-775.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Sholl, Lynette M., et al. "Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies."
Archives of Pathology & Laboratory Medicine 148, no. 7 (2024): 757-775.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Sholl, Lynette M., et al. "Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies."
Archives of Pathology & Laboratory Medicine, vol. 148, no. 7, 2024, pp. 757-775.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.